Journal
MOLECULAR BIOLOGY OF THE CELL
Volume 17, Issue 11, Pages 4686-4697Publisher
AMER SOC CELL BIOLOGY
DOI: 10.1091/mbc.E06-04-0289
Keywords
-
Categories
Funding
- NHLBI NIH HHS [R01 HL75092, R01 HL075092, HL56595, R01 HL056595] Funding Source: Medline
Ask authors/readers for more resources
Atherosclerotic plaque develops at sites of disturbed flow. We previously showed that flow activates endothelial cell integrins, which then bind to the subendothelial extracellular matrix (ECM), and, in cells on fibronectin or fibrinogen, trigger nuclear factor-kappa B activation. Additionally, fibronectin and fibrinogen are deposited into the subendothelial ECM at atherosclerosis-prone sites at early times. We now show that flow activates ECM-specific signals that establish patterns of integrin dominance. Flow induced alpha 2 beta 1 activation in cells on collagen, but not on fibronectin or fibrinogen. Conversely, alpha 5 beta 1 and alpha v beta 3 are activated on fibronectin and fibrinogen, but not collagen. Failure of these integrins to be activated on nonpermissive ECM is because of active suppression by the integrins that are ligated. Protein kinase A is activated specifically on collagen and suppresses flow-induced alpha v beta 3 activation. Alternatively, protein kinase C alpha is activated on fibronectin and mediates alpha 2 beta 1 suppression. Thus, integrins actively cross-inhibit through specific kinase pathways. These mechanisms may determine cellular responses to complex extracellular matrices.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available